0001104659-19-033993.txt : 20190717 0001104659-19-033993.hdr.sgml : 20190717 20190605143703 ACCESSION NUMBER: 0001104659-19-033993 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001583771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462783806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 BUSINESS PHONE: 732-902-4000 MAIL ADDRESS: STREET 1: 399 THORNALL STREET STREET 2: FIRST FLOOR CITY: EDISON STATE: NJ ZIP: 08837 CORRESP 1 filename1.htm

 

ContraVir Pharmaceuticals, Inc.

399 Thornall Street

Edison, NJ 08837

 

June 5, 2019

 

VIA EDGAR

United States Securities

and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Attention: Dorrie Yale

 

Re:                             ContraVir Pharmaceuticals, Inc.

Form S-1

File No. 333-231604

 

Dear Ms. Yale:

 

ContraVir Pharmaceuticals, Inc. (the “Company”) hereby respectfully withdraws its request, dated June 5, 2019, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Thursday, June 5, 2019. The Company intends to submit a revised acceleration request at a later date.

 

Please contact Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 if there are any questions with respect to this request.

 

 

Thank you,

 

 

 

CONTRAVIR PHARMACEUTICALS, INC.

 

 

 

By:

/s/ Robert Foster

 

Name: Robert Foster

 

Title: Chief Executive Officer